However, semaglutide is covered by Medicare as a treatment for diabetes, branded as Ozempic
Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, et al
Discontinuation due to factors typically irrelevant in clinical trial settings (i.e., cost or insurance-related issues and medication shortages) could contribute to the substantial discrepancy between discontinuation rates in pivotal phase 3 trials and those reported in real-world studies. Regarding discontinuation due to side effects, Gasoyan says we do not currently know of patient-level predictors that would help identify who might experience side effects and why
There are many domestic cooperative customers such as CNNC, Yili, Shenmu Longhua, CASIC etc
Most participants (80.8%) remained on low maintenance doses
A person with advanced kidney disease or other medical restrictions may need a different plan